StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

Research analysts at StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Trading Down 7.0 %

NASDAQ AEMD opened at $0.80 on Friday. The company has a fifty day simple moving average of $0.45 and a 200 day simple moving average of $0.43. The company has a market cap of $11.17 million, a P/E ratio of -0.28 and a beta of 1.79. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.24.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.